Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Adamis Pharmaceuticl (NASDAQ: ADMP)

$3.70 USD -$0.10 (-2.63%)
Last Price $3.7
Net Change $-0.1 (-2.63%)
Bid $0
Ask Price $0
Open Price $3.85
Previous Close Price $3.8
High Price $3.9
Low Price $3.65
Number of Trades 877
Volume 413,800
Fifty Two Week High $9.08 (2016-06-02)
Fifty Two Week Low $2.4 (2016-10-27)
Average Daily Volume 425,223
Share Outstanding 27,560 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $42.86
Recent Earnings $
Annual EPS $-1.04
Last Quarter EPS $
Market Capitalization $0.10B
Insider Shareholders % 0.096%
Annual Revenue $0B
No. Shares Outstanding 27,560
Inst. Shareholder % 11.18%
Annual Net Income $-0.02B
TTM Net Profit Margin $-197.37
1-Year Return -57.76%
3-Year Return -36.1%
5-Year Return -66.52%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 42.860001%
Dividends per Share $
Stock Split Ratio 1-17
Beta 0.06
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.

ADMP News & Stock Updates